HES1 and colorectal cancer: The co-expression of Hes1 and ARID3B is associated with poor prognosis in colorectal cancer, and they may synergistically recruit histone-modifying enzymes (such as KDM4C) to regulate chromatin structure, thereby activating PD-L1 immune checkpoint transcription and inhibiting T cell activity (140).